Opendata, web and dolomites


Applying voltage-imaging techniques to visualise the effect of lysergic acid diethylamide (LSD) on cortical layer V pyramidal cells and its adaptation during tolerance development

Total Cost €


EC-Contrib. €






 LSD-CortLVPC project word cloud

Explore the words cloud of the LSD-CortLVPC project. It provides you a very rough idea of what is the project "LSD-CortLVPC" about.

shg    benefit    popular    triangle    rank    vivo    mediated    faced    discussed    pfel    psych    competitive    health    butterfly    relevance    cortex    prof    brain    serotonin    translates    acid    interpreted    diethylamide    accounted    abuse    speculative    receptors    activation    thomas    mice    investigations    techniques    re    politics    animals    scientific    alpha    dipl    sensitive    ethological    pioneering    hallucinogens    submissiveness    potentially    pose    desynchronise    primarily    pathophysiology    networks    pivot    postulated    hallucinogen    living    serotonergic    imminent    layer    inhibit    neuropsychopharmacology    cortical    gained    lsd    unresolved    area    kn    reveals    selective    waking    brings    regard    cells    agents    lvpcs    drugs    genetically    fluorescent    imaging    psychotherapy    applies    optogenetic    vitro    neuropharmacological    threat    observations    ouml    voltage    pyramidal    psychoactive    society    promotors    action    lvpc    interaction    electrophysiology    metabolism    ht2a    controversially    controversy    expertise    2a    psychosis    scientifically    combines    modern    disconnect    buchborn    elucidate    oscillations    basis    lysergic    detriment    tobias    point    science    glutamate    excitability    protein    virtually   

Project "LSD-CortLVPC" data sheet

The following table provides information about the project.


Organization address
city: LONDON
postcode: SW7 2AZ

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website
 Total cost 183˙454 €
 EC max contribution 183˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2018-05-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Serotonergic hallucinogens (sHG), such as lysergic acid diethylamide (LSD), rank among the most controversially discussed agents of modern neuropsychopharmacology. They are popular drugs of abuse, scientifically are used to study the pathophysiology of psychosis, can pose a threat to health, but most recently also re-gained attention as promotors of psychotherapy. The controversy at hand remains unresolved by modern science and politics, and the European Research Area is faced with the imminent challenge to come up with a strong and competitive scientific basis that is able to elucidate how these drugs work and how their working potentially translates into benefit and/or detriment to European health and society. The psychoactive effects of sHG are mediated by activation of serotonin 2A (5-HT2A) receptors within the cortex of the brain. In vivo, sHG disconnect cortical networks, desynchronise alpha oscillations and inhibit the metabolism of the cortex. In vitro, sHG primarily enhance the excitability of cortical layer V pyramidal cells (LVPCs), which is accounted for by 5-HT2A-glutamate interaction. The in vivo effects of sHG often are interpreted with regard to their in vitro effects. As there are virtually no LVPC specific investigations in living animals, however, the in vivo relevance of the postulated 5-HT2A-LVPC-glutamate triangle is highly speculative. Our project brings together Prof. Thomas Knöpfel, who has been pioneering optogenetic electrophysiology, and the 5-HT2A-hallucinogen expertise of Dipl. Psych. Tobias Buchborn. It applies advanced techniques of voltage imaging (with the voltage-sensitive fluorescent protein Butterfly 1.2 genetically targeted to LVPCs), combines them with selective neuropharmacological challenges and 5-HT2A specific ethological observations, and reveals within the brain of waking mice whether it is indeed LVPCs and their submissiveness to 5-HT2A-glutamate interaction that represent the point pivot of the cortical action of LSD.


year authors and title journal last update
List of publications.
2018 Tobias Buchborn, Taylor Lyons, Thomas Knöpfel
Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
published pages: , ISSN: 1663-9812, DOI: 10.3389/fphar.2018.00017
Frontiers in Pharmacology 9 2019-06-13

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LSD-CORTLVPC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LSD-CORTLVPC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

POMOC (2019)

Charles IV and the power of marvellous objects

Read More  

iRhomADAM (2020)

Uncovering the role of the iRhom2-ADAM17 interaction in inflammatory signalling

Read More  

COLEX (2019)

Coopetition and Legislation in the Spanish Netherlands (1598-1665)

Read More